Skip to main content

Table 2 ORS and zinc treatment coverage by subgroup

From: Private health care market shaping and changes in inequities in childhood diarrhoea treatment coverage: evidence from the analysis of baseline and endline surveys of an ORS and zinc scale-up program in Nigeria

 

Received ORS

Received Zinc

 

Baseline n = 1349%, 95 confidence interval

Endline n = 2023%, 95 confidence interval

Endline - Baseline Difference 95% confidence interval, P-value*

Baseline n = 1333%, 95 confidence interval

Endline n = 2000%, 95 confidence interval

Endline - Baseline Difference 95% confidence interval, P-value*

Residence of households

 Urban

44 (36–51)

50 (49–54)

6 (− 3.2–15), 0.210

6 (3–9)

29 (25–33)

23 (18–28), <  0.001

 Rural

39 (35–42)

57 (53–60)

18 (13–23), <  0.001

5 (4–7)

38 (35–41)

33 (29–36), <  0.001

Wealth quintiles

 Poorest

28 (22–35)

50 (44–56)

21 (12–31), <  0.001

3 (1–5)

35 (30–40)

33 (27–38), <  0.001

 Second

37 (28–46)

51 (46–57)

15 (4–25), 0.006

3 (1–6)

31 (25–36)

27 (21–33), <  0.001

 Middle

43 (34–52)

47 (41–53)

4 (−7–15), 0.462

4 (1–6)

25 (20–29)

21 (16–26), <  0.001

 Fourth

47 (37–56)

54 (47–60)

7 (−5–18), 0.242

7 (3–10)

33 (29–38)

27 (21–32,), <  0.001

 Richest

50 (52–58)

67 (61–73)

17 (7.3–27), 0.001

10 (5–15)

40 (40–52)

36 (28–44), <  0.001

  1. *P-values were generated using Wald’s chi-squared tests